benphothiamine has been researched along with Metabolic Syndrome in 2 studies
benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opolonskiĭĭ, DV | 1 |
| Maksimov, NI | 2 |
| Opolonskiĭ, DV | 1 |
2 trials available for benphothiamine and Metabolic Syndrome
| Article | Year |
|---|---|
[Structural and functional changes of arterial vessels in patients with ischemic heart disease and metabolic syndrome].
Topics: Adult; Body Mass Index; Coronary Vessels; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Myo | 2009 |
[Correction of metabolic disturbances in patients with stable effort angina and metabolic syndrome].
Topics: Adjuvants, Immunologic; Adult; Angina Pectoris; Dose-Response Relationship, Drug; Female; Follow-Up | 2009 |